“…For example, there is strong attention to study details, study quality per se (e.g., Becker & Curry, ; Sprenkle, ), as well as conflicting interpretations of findings from a single study or, usually via meta‐analysis, from a set of studies (Kazdin, ). Controversies exist about program effectiveness (Drug and Alcohol Findings, ; Henggeler, Schoenwald, Borduin, & Swenson, ; Littell, , ; Littell, Popa, & Burnee, ; Ogden & Hagen, ; The Campbell Collaboration, ), approach evaluations (discussed in Lindstrøm et al., ; Gambrill & Littell, ; and van der Stouwe, Asscher, Stams, Dekovi'c, & van der Laan, ), transporting family based interventions across cultures (Burkhart, ), trademarking and brand naming of established therapies (Bean, ; Eisler, ; Imber Black, ), and the unavailability of evidence‐based therapy training for most practitioners (Barth et al., ; Hogue, Henderson, Ozechowski, & Robbins, ). And, these discussions inform suggestions about needed work.…”